Read the Latest News

And the Committee heard from the American Association of Oral and Maxillofacial Surgeons

At the end of the NAM meeting, Dr. Gregory Ness, representing the American Association of Oral and Maxillofacial Surgeons (AAMOS) gave the following comments: “AAMOS welcomes the interest and support of the Academies, the NIH, NIDCR, FDA and The

What Allen Told the Committee

Allen Cowley addressed the second open-to-the-public meeting of the National Institute of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD) held on March 28, 2019 in Washington, DC. No stranger to the world of TMD, Dr. Cowley is the hus

Some Thoughts on Depression

It is hardly surprising that the chronic pain and limitations in function that many long-time TMJ patients experience can be accompanied by a state of depression, a sense of exhaustion and hopelessness.

Upcoming NAM Public Webinars on TMD

The National Academy of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment is hosting two public web conferences on Wednesday, June 19 and Wednesday, July 31.   Webinar 1: Pati

The NAM Committee Heard from Patients, Too

At the March 28, 2019 public meeting NAM committee members had a chance to hear from TMD patients who had submitted testimony for the record.

Survey Profiles TMD Patients

  • Jan 14, 2015

TMJA Survey Results

  • The individuals affected by Temporomandibluar Joint Disorders (TMD) were on average 41 years of age and predominantly female (90%).
  • Nearly 60% of both men and women reported recent pain of moderate-to-severe intensity with a quarter of them indicating interference or termination of work-related activities.
  • In the case-control comparison, a higher frequency of headaches, allergies, depression, fatigue, degenerative arthritis, fibromyalgia, autoimmune disorders, sleep apnea, and gastrointestinal complaints were prevalent among those affected with TMD. Many of the associated comorbid conditions were over 6 times more likely to occur after TMD was diagnosed.
  • Among a wide array of treatments used (46 listed), the most effective relief for most affected individuals (91%) was the use of thermal therapies—hot/cold packs to the jaw area or hot baths.
  • Nearly 40% of individuals affected with TMD reported one or more surgical procedures and nearly all were treated with one or many different medications. Results of these treatments were generally equivocal.

How the TMJA's Survey Came About...

Since The TMJ Association began in 1986, we have been privy to TMJ experiences. We’ve heard from patients and family members here and abroad via phone, fax, mail, and email--all sharing stories of pain and problems with speaking, chewing, swallowing, and even kissing loved ones.
 
There were grim stories about trying to find an understanding practitioner, the cost of care, the lack of insurance and even worse—accounts of failed treatments.  You’ve shared ideas for coping and alleviating pain. Other times, you described additional health problems that seemed to develop along with the Temporomandibular Disorder (TMD).

Because of your input, the TMJA has been able to  gather a wealth of information about TMD in all their complexity. Not surprisingly, it occurred to us that there should be a way to organize this information in such a way as to provide patients, providers, and scientists with a fuller understanding of these conditions - who experiences them, and the treatments being recommended to TMJ patients and whether these treatments help them.

Thus was born the idea of a major survey to be designed, conducted, and analyzed by outside experts whose participation would lend credibility to the survey. With headquarters in Milwaukee and access to the Medical College of Wisconsin (MCW), the TMJA contacted four MCW professors who rose to the challenge: Raymond Hoffman, PhD, is a biostatistician and Associate Director of Quantitative Health Sciences in MCW’s Department of Pediatrics, Jane Morley Kotchen, MD, MPH, Director and Professor in the Master in Public Health Program of the Institute for Health and Society, Theodore Kotchen, MD, Professor of Medicine and Associate dean for Clinical Research, in the Department of Medicine Division of Endocrinology, Metabolism, and Clinical Nutrition, and Allen W. Cowley, Jr., Ph.D., Director of the Cardiovascular Center & Chairman of the Department of Physiology.

Together, the team, working with TMJA, drafted an extensive questionnaire demographic information (age, sex, marital status), reproductive history, family history of TMD, age at which the symptoms first occurred and age of diagnosis, respondent’s concepts about causes of symptoms, procedures related to TMD, and selected medications. We also wanted to identify the spectrum of clinical manifestations and therapeutic strategies associated with TMD from the perspective of the affected individuals, and to compare the prevalence of comorbid conditions and symptoms in affected individuals to a comparable group of unaffected individuals similar in age and sex.

Review and approval of the survey and protocol by MCW’s Institutional Review Board (mandated to protect the rights of human subjects) took several months, but in due course the invitation to participate was electronically mailed to 10,000 TMJA registrants. A little over one-third of the registrants actually received the invitation and 43 percent responded, for a total of 1,511 respondents, 1,358 women and 153 men. Our thanks go to the survey participants and scientists who made this possible. Results of the survey were published in the Clinical Journal of Pain, Volume 27, Number 3, March/April 2011, pp. 268-274.

Dr. Jane Kotchen, a co-author of the survey presented the findings at the TMJA's Fourth Scientific Meeting. Click here to view the PowerPoint presentation.

TMJ Disorders

Comments:

Login or Register to add Comment